ACTON, Mass.--(BUSINESS WIRE)--Feb. 8, 2021-- Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at three upcoming virtual investor conferences:
- The Citi 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference on Thursday, February 25, 2021 at 9:50 a.m. (Eastern Time)
- The Raymond James & Associates 42nd Annual Institutional Investors Conference on March 1, 2021 at 8:20 a.m. (Eastern Time)
- The Cowen 41st Annual Health Care Conference on Tuesday, March 2, 2021 at 9:10 a.m. (Eastern Time)
To listen to live audio webcasts of the presentations, please visit http://investors.insulet.com. Replays of the webcasts will also be available following the events.
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: www.insulet.com and www.omnipod.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210208005741/en/
Deborah R. Gordon
Vice President, Investor Relations
Principal Investor Relations Analyst
Angela Geryak Wiczek
Senior Director, Corporate Communications
Source: Insulet Corporation